---
layout: minimal-medicine
title: Carmustine
---

# Carmustine
### Generic Name
Carmustine

### Usage
Carmustine is a chemotherapy drug used to treat various types of cancer.  Its primary use is in treating brain tumors, particularly glioblastoma multiforme and other high-grade malignant gliomas.  It's often used in combination with other chemotherapy drugs but can also be administered as a single agent.  Secondary uses include treating multiple myeloma, Hodgkin's lymphoma, and non-Hodgkin's lymphoma, again either alone or as part of a combination regimen.  Off-label uses include treating mycosis fungoides (a type of skin cancer). The method of administration varies depending on the cancer being treated; it can be given intravenously (IV), implanted as wafers directly into the tumor site (for brain tumors), or applied topically (for mycosis fungoides).


### Dosage

Dosage of carmustine varies greatly depending on several factors, including the specific type of cancer, the patient's overall health (particularly liver and kidney function), and whether it's given as a single agent or in combination with other drugs.  Always follow the guidance of the prescribing oncologist.

**Intravenous (IV) Administration:**

* **Brain tumors, multiple myeloma, Hodgkin's lymphoma, non-Hodgkin's lymphoma:** Dosages typically range from 150-200 mg/m² every 6 weeks, administered over at least 2 hours. Alternatively, a dose of 75-100 mg/m²/day for two days every six weeks may be used.  The oncologist will determine the optimal schedule and dosage.

* **Hodgkin's lymphoma (relapsed or refractory):**  In combination therapy (Mini-BEAM regimen), a dose of 60 mg/m² on day 1 every 4-6 weeks is common.

* **Stem cell or bone marrow transplant (off-label):** Dosages vary greatly depending on the specific regimen.  For example, the BEAM regimen may utilize a single dose of 300 mg/m² six days before transplant, while the CBV regimen could use 600 mg/m² three days prior.

**Wafer Implantation (for brain tumors):**

* Typically, 8 wafers (61.6 mg total dose) are implanted into the surgical cavity following tumor resection.

**Topical Application (off-label, for mycosis fungoides):**

* Dosage varies greatly.  An ointment may be applied once daily to affected areas, and a solution (0.5-3 mg/mL in 30% alcohol) can also be used in the same manner.


**Pediatric Dosage:**

The safety and efficacy of carmustine in children have not been established.


**Dosage Adjustments:**  Dosage adjustments are often necessary based on factors such as kidney and liver function, and blood counts (specifically, white blood cell and platelet levels).  These adjustments must be made by the prescribing oncologist.


### Side Effects

Carmustine can cause a wide range of side effects, varying in severity and frequency.  These can differ based on the method of administration and dosage.

**Common Side Effects (Intravenous):**  Nausea, vomiting, anemia, low white blood cell count (leukopenia), low platelet count (thrombocytopenia).

**Less Common but Serious Side Effects (Intravenous):**  Pulmonary toxicity (lung damage), kidney damage, liver damage, heart problems, nerve damage, secondary cancers (long-term risk).  Severe allergic reactions are also possible.

**Side Effects (Wafer Implantation):**  These are frequently localized around the implantation site and can include pain, swelling, infection, and neurological problems.  Systemic effects are also possible.

**Side Effects (Topical):**  Local skin reactions at the application site are most common.

**Note:** This is not an exhaustive list.  If any adverse effects occur, consult a healthcare provider immediately.


### How it Works

Carmustine is an alkylating agent, a type of chemotherapy drug that works by damaging the DNA of cancer cells, preventing them from reproducing and leading to their death.  It's classified as a cell-cycle phase nonspecific agent, meaning it can affect cancer cells regardless of their stage in the cell cycle. While the exact mechanism isn't fully understood, it's thought to involve both alkylation and carbamoylation of cellular components.


### Precautions

* **Hypersensitivity:** Carmustine is contraindicated in individuals with known hypersensitivity to the drug or any of its components.

* **Bone Marrow Suppression:**  Carmustine significantly suppresses bone marrow function, increasing the risk of infections and bleeding.  Regular blood tests are crucial to monitor this.

* **Pulmonary Toxicity:**  Carmustine can cause lung damage, both acutely and in the long term.  This risk increases with cumulative dose.

* **Hepatic and Renal Impairment:**  Caution is advised in patients with liver or kidney disease, as dose adjustments are often required.

* **Pregnancy and Breastfeeding:**  Carmustine is a Category D drug, meaning it can cause fetal harm.  Pregnant women should not use it.  Breastfeeding should be discontinued during treatment and for several days after.

* **Drug Interactions:** Carmustine may interact with other medications, including live vaccines and other immunosuppressants.  Inform your oncologist of all medications being taken.

* **Alcohol:**  Alcohol consumption should be avoided.


### FAQs

* **Q: How long does it take for Carmustine to work?**  A: The response to Carmustine varies depending on the individual and the cancer being treated.  It's not a fast-acting drug, and treatment usually involves multiple cycles.

* **Q: How is Carmustine stored?** A: Storage instructions will vary based on the formulation (IV solution, wafers, topical). Follow the directions provided with your medication.

* **Q: What should I do if I miss a dose?** A: Contact your oncologist immediately.  Do not attempt to adjust your dosage yourself.

* **Q: Are there any long-term effects of Carmustine?** A:  Yes, there are potential long-term risks, including secondary cancers and organ damage (particularly to the lungs and kidneys). Regular monitoring is important.

* **Q: Can I take other medications while using Carmustine?**  A:  It's crucial to inform your oncologist of all medications you are taking to avoid potential drug interactions.

**Disclaimer:** This information is intended for general knowledge and should not be considered medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The specific dosage and administration of Carmustine will be determined by your oncologist based on your individual circumstances.
